De-cancer / curatio / medicinae / pellis
Medicamenta probatum est Cutis Cancer
Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) pro pelle cancer, possidet medicinae ad basem, cellula basali carcinoma melanoma, et merkel cell carcinoma. Album quod includit nomina generica et torris nomen. Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. In cute cancer medicinae potest non fieri ut non hic enumerantur.
On this page
- Medicamenta probatum est radicale Carcinoma
- Medicamenta Approbata pro Cutaneous Plattenepithelkarzinom
- Medicamenta Approbata pro Carcinoma
- Medicamenta Approbata pro Merkel Carcinoma
Medicamenta probatum est radicale Carcinoma
Aldara (Imiquimod)
Efudex (Fluorouracil - General)
Erivedge (Vismodegib)
FU-V (Fluorouracil - General)
Fluorouracil - Personal Name
Imiquimod
Odomzo (Sonidegib)
Sonidegib
Vismodegib
Medicamenta Approbata pro Cutaneous Plattenepithelkarzinom
Cemiplimab rwlc,
Libtayo (Cemiplimab, rwlc)
Medicamenta Approbata pro Carcinoma
Aldesleukin
Cobimetinib
Cotellic (Cobimetinib)
Dabrafenib
Dacarbazine
DTIC, Dome (Dacarbazine)
II-II (Aldesleukin)
Imlygic (Talimogene Laherparepvec)
Interleuquina-II (Aldesleukin)
A Intrón (recombinante Interferón alfa-2a)
Ipilimumab
Keytruda (Pembrolizumab)
Mekinist (Trametinib)
Nivolumab
Opdivo (Nivolumab)
Alfa-2a Peginterferon
Pembrolizumab
Proleukin (Aldesleukin)
Recombinante alfa-2a Interferón
Sylatron (Peginterferon alfa-2a)
Tafinlar (Dabrafenib)
Talimogene Laherparepvec
Trametinib
Vemurafenib
Yervoy (Ipilimumab)
Zelboraf (Vemurafenib)
Medicamenta Approbata pro Merkel Carcinoma
Avelumab
Bavencio (Avelumab)
Keytruda (Pembrolizumab)
Pembrolizumab
